It’s African American History Month, and, here at LifeBrite Laboratories, we’re looking back and paying tribute to some of the many Black scientists and doctors whose work made medical laboratories possible. Their insights, innovations, and advances equip LifeBrite...
While COVID-19 rightly remains the focus of national healthcare news, heart disease is still the leading cause of death. Your patients with cardiovascular diseases — especially heart failure, coronary artery disease, cardiomyopathies, and pulmonary hypertension — may...
With January being Cervical Health Awareness Month, it’s worth remembering that, according to the CDC, cervical cancer was once “the leading cause of cancer death for women in the United States.” Then came the Papanicolaou (Pap) test, introduced in the U.S. in the...
Chronic care management of multimorbidity patients almost always brings polypharmacy along for the ride. This makes effective medication reconciliation and monitoring essential for quality care. You know well the risks of polypharmacy to your patients. According to...
Tens of millions of American women are impacted by bacterial vaginosis and vulvovaginal candidiasis each year. According to the CDC, bacterial vaginosis affects 21.2 million women (29.2%) between the ages of 15 and 49, making it the most common vaginal infection in...
It’s American Diabetes Month and, here at LifeBrite Laboratories, we’ve been thinking a lot about how we can help physicians select the most effective treatment options for their diabetic patients. Pharmacogenomics have been used for years in rare monogenic forms of...
